semaglutide for prediabetes RCT: In patients with #schizophrenia, #prediabetes, and #obesity, once-weekly #semaglutide injections, up to 1.0 mg/week, were safe and effective. https://t.co/u7CwGLDs1E Semaglutide vs. Other GLP-1 Receptor
Description
Semaglutide has become a widely used medication for weight management , offering a structured and sustainable approach to losing weight
Injection site reactions such as redness, itching, or swellingcan occur
When blood sugar rises after a meal, GLP-1 amplifies the pancreas's insulin response
This is the dose that showed the most significant weight loss in clinical trials
Currently, Retatrutide is not FDA-approved for human use and can only be studied in lab environments and for research purposes
